Insmed Growth Agent iPlex Joins Tercica's Increlex With Orphan Drug Designation
FDA approves iPlex for the same indication as Increlex, but both products are granted orphan drug exclusivity.
FDA approves iPlex for the same indication as Increlex, but both products are granted orphan drug exclusivity.